Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors. 2016

Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
Department of Applied Chemistry, China Agricultural University, Beijing 100193, China.

Human O-GlcNAcase (GH 84) and human β-N-acetyl-D-hexosaminidase (GH 20) from Homo sapiens are two therapeutic enzyme targets that share the same catalytic mechanism but play different physiological roles in vivo. Selective inhibition toward one of these enzymes is therefore of importance to regulate the corresponding bioprocess. Here ten new NAM-thiazoline derivatives were synthesized and subsequently characterized by NMR and HRMS. A preliminary bioassay showed that most of the synthesized compounds exhibited obvious selective inhibition against human O-GlcNAcase over human β-N-acetyl-D-hexosaminidase. Among the compounds tested, compound 7d (IC50 = 6.4 µM, hOGA; IC50>1 mM, hHex) and 7f (IC50 = 11.9 µM, hOGA; IC50>1 mM, hHex) proved to be a highly selective and potent inhibitor. Structure-activity relationship analysis indicated a correlation between the inhibitory activity and the size of the groups linked to the thiazoline ring.

UI MeSH Term Description Entries
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000117 Acetylglucosamine The N-acetyl derivative of glucosamine. Acetyl Glucosamine,N-Acetyl Glucosamine,N-Acetyl-beta-D-Glucosamine,N-Acetylglucosamine,beta-N-Acetylglucosamine,2-Acetamido-2-Deoxy-D-Glucose,2-Acetamido-2-Deoxyglucose,N-Acetyl-D-Glucosamine,2 Acetamido 2 Deoxy D Glucose,2 Acetamido 2 Deoxyglucose,Glucosamine, Acetyl,Glucosamine, N-Acetyl,N Acetyl D Glucosamine,N Acetyl Glucosamine,N Acetyl beta D Glucosamine,N Acetylglucosamine,beta N Acetylglucosamine
D001619 beta-N-Acetylhexosaminidases A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. beta-N-Acetylhexosaminidase,N-Acetyl-beta-D-hexosaminidase,beta-Hexosaminidase,beta-N-Acetyl-D-hexosaminidase,beta-N-Acetyl-hexosaminidase,N Acetyl beta D hexosaminidase,beta Hexosaminidase,beta N Acetyl D hexosaminidase,beta N Acetyl hexosaminidase,beta N Acetylhexosaminidase,beta N Acetylhexosaminidases
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole

Related Publications

Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
March 2006, Organic & biomolecular chemistry,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
February 2016, Drug development research,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
January 1999, Die Pharmazie,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
July 1971, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
July 2011, Carbohydrate research,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
February 2017, Archiv der Pharmazie,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
September 2010, Bioorganic & medicinal chemistry letters,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
January 2015, FEBS letters,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
January 2019, Frontiers in chemistry,
Hanchu Kong, and Wei Chen, and Tian Liu, and Huizhe Lu, and Qing Yang, and Yanhong Dong, and Xiaomei Liang, and Shuhui Jin, and Jianjun Zhang
December 2018, ACS medicinal chemistry letters,
Copied contents to your clipboard!